# Axovan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/axovan

- Industry: Biotechnology
- Headquarters: Allschwil, Switzerland
- Total disclosed funding: $23M
- Latest round: Series B (Apr 22, 2002)
- Investors on record: 7

## About

Axovan is based in Switzerland and operates as a Biotech firm which engages in development of innovative drugs using human genome information.

## Funding rounds

- Series B, Apr 22, 2002, $18M — Atlas Venture, Heidelberg Innovation Funds Management, Venture Partners, NeoMed, Banque Cantonale Vaudoise, Reference Cap AG, New Medical Technologies
- Series A, Jun 1, 2000, $4.9M — Venture Partners, Reference Cap AG, New Medical Technologies

## Investors

- Venture Partners (https://capitalatlas.ai/funds/venture-partners) — Series A, Series B
- Reference Cap AG — Series A, Series B
- New Medical Technologies — Series A, Series B
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B
- Heidelberg Innovation Funds Management (https://capitalatlas.ai/funds/heidelberg-innovation-funds-management) — Series B
- NeoMed (https://capitalatlas.ai/funds/neomed) — Series B
- Banque Cantonale Vaudoise — Series B